Patents by Inventor Enca Martin-Rendon

Enca Martin-Rendon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR EVALUATING ANGIOGENIC POTENTIAL
    Publication number: 20130108594
    Abstract: The invention provides a method for determining the angiogenic signature of a cell or tissue sample and methods for predicting efficacy of angiogenic therapy, for preparing a predictive model for predicting angiogenic potential, for identifying an agent for use in angiotherapy and therapeutic agents and applications.
    Type: Application
    Filed: April 28, 2011
    Publication date: May 2, 2013
    Applicant: NHS BLOOD & TRANSPLANT
    Inventors: Enca Martin-Rendon, Suzanne Watt
  • Vector system
    Patent number: 7259015
    Abstract: Provided are retroviral vector genomes and vector systems comprising the genomes. In particular, a retroviral vector genome comprising two or more NOIs, operably linked by one or more Internal Ribosome Entry Site(s); a lentiviral vector genome comprising two or more NOIs suitable for treating a neurodegenerative disorder; and a lentiviral vector genome which encodes tyrosine hydroxylase, GTP-cyclohydrolase I and, optionally, Aromatic Amino Acid Dopa Decarboxylase are provided.
    Type: Grant
    Filed: April 7, 2003
    Date of Patent: August 21, 2007
    Assignee: Oxford Biomedia (UK) Limited
    Inventors: Alan John Kingsman, Nicholas D. Mazarakis, Enca Martin-Rendon, Mimoun Azzouz, Jonathan Rohll
  • Vector system
    Publication number: 20070025970
    Abstract: The present invention relates to retroviral vector genomes and to vector systems comprising such genomes. In particular the present invention relates to a retroviral vector genome comprising two or more NOIs operably linked by one or more Internal Ribosome Entry Site(s); a lentiviral vector genome comprising two or more NOIs suitable for treating a neurodegenerative disorder; and a lentiviral vector genome which encodes tyrosine hydroxylase, GTP-cyclohydrolase I and optionally Aromatic Amino Acid Dopa Decarboxylase.
    Type: Application
    Filed: July 14, 2006
    Publication date: February 1, 2007
    Inventors: Alan Kingsman, Nicholas Mazarakis, Enca Martin-Rendon, Mimoun Azzouz, Jonathan Rohll
  • Vector system
    Publication number: 20040013648
    Abstract: Provided are retroviral vector genomes and vector systems comprising the genomes. In particular, a retroviral vector genome comprising two or more NOIs, operably linked by one or more Internal Ribosome Entry Site(s); a lentiviral vector genome comprising two or more NOIs suitable for treating a neurodegenerative disorder; and a lentiviral vector genome which encodes tyrosine hydroxylase, GTP-cyclohydrolase I and, optionally, Aromatic Amino Acid Dopa Decarboxylase are provided.
    Type: Application
    Filed: April 7, 2003
    Publication date: January 22, 2004
    Inventors: Alan John Kingsman, Nicholas D. Mazarakis, Enca Martin-Rendon, Mimoun Azzouz, Jonathan Rohll